Back
Adaptimmune Therapeutics PLC Stock Price Chart
![](/images/offers/ims/large/offer13.jpg)
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.
Sell
44
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.11
Seasonality Move:
-8.14%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
FREE Report: Could these High Yield Stocks wreck your retirement?
Get Your Copy of "20 High-Yield Dividend Stocks that Could Ruin Your Retirement" Here.- The current trend is relatively stagnant and ADAP is experiencing slight selling pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.96 | Buy |
20-day SMA: | 0.97 | Buy |
50-day SMA: | 1.06 | Sell |
200-day SMA: | 0.94 | Buy |
8-day EMA: | 0.99 | Buy |
20-day EMA: | 0.99 | Buy |
50-day EMA: | 1.05 | Sell |
200-day EMA: | 1.07 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 52.04 | Buy |
Chaikin Money Flow: | -245892 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.91 - 1.07) | Buy |
Bollinger Bands (100): | (0.99 - 1.45) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 1.02 while ADAP 8-day simple moving average is 0.96, which is a Buy signal.
- The stock price of ADAP is 1.02 while Adaptimmune Therapeutics PLC 20-day SMA is 0.97, which makes it a Buy.
- Adaptimmune Therapeutics PLC 50-day simple moving average is 1.06 while ADAP share price is 1.02, making it a Sell technically.
- ADAP stock price is 1.02 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.94, creating a Buy signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
44
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a Sell
The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.02. The Score for ADAP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
260.67M
Price in USD:
1.02
Share Volume:
737.68K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
2.05
52-Week Low:
0.42
Sell
44
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?
The Adaptimmune Therapeutics PLC stock price is 1.02 USD today. -
Will ADAP stock go up or go down?
Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptimmune Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 1.02 while ADAP 8-day exponential moving average is 0.99, which is a Buy signal.
- The stock price of ADAP is 1.02 while Adaptimmune Therapeutics PLC 20-day EMA is 0.99, which makes it a Buy.
- Adaptimmune Therapeutics PLC 50-day exponential moving average is 1.05 while ADAP share price is 1.02, making it a Sell technically.
- ADAP stock price is 1.02 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.07, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
- ADAP Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Adaptimmune Therapeutics PLC is a Sell
- Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 52.04, which suggest Adaptimmune Therapeutics PLC is overbought
- The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.91 - 1.07), which suggest Adaptimmune Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.99 - 1.45), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.